Sangamo Biosciences reported $309.15M in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Amgen AMGN:US USD 3.65B 1.23B
Avrobio Inc AVRO:US USD 98.09M 20.25M
Bayer BAYN:GR EUR 41.27B 3.25B
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Biogen BIIB:US USD 12.78B 903M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Gilead Sciences GILD:US USD 21.06B 821M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Novartis NOVN:VX USD 60.82B 2.1B
Omeros OMER:US USD -46314000 13.61M
Regulus Therapeutics RGLS:US USD 39.67M 2.7M
Roche Holding ROG:VX 25.19B 700M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
Ziopharm Oncology ZIOP:US USD 32.11M 8.07M